Skip to main content

Helicos Receives $700K Cash Advance

Premium

Helicos has received a $700,000 cash advance from Atlas Venture and Flagship Ventures as part of a bridge loan agreement Helicos entered into last year with those investment firms, according to documents filed with the US Securities Exchange Commission.

The deal comes just a few weeks after Helicos reported that it would require "significant additional capital" in December to keep operating (IS 11/15/2011).

In the original financing deal, Helicos agreed to sell up to $4 million worth of convertible promissory notes to Atlas Ventures and Flagship Ventures, with a total committed purchase amount of $2 million and the right to purchase up to an additional $2 million on or before Dec. 31, 2012 (IS 11/30/2010).

As part of this latest cash advance, the firms amended the original agreement to say that Atlas and Flagship would purchase notes at least once more before Dec. 31, 2012, for no more than $1 million.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.